Prenatal testing for maternal serum alpha-fetoprotein

E. J. Schwager, B. D. Weiss

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

The maternal serum alpha-fetoprotein level should be measured in all pregnant women at 16 to 20 weeks of gestation. Elevated alpha-fetoprotein levels require evaluation by ultrasonography and, sometimes, amniocentesis to detect neural tube defects. Low alpha-fetoprotein levels may be associated with chromosomal anomalies and should be evaluated with amniocentesis. Alpha-fetoprotein testing is cost-effective, and medicolegal liability makes it imperative to offer this screening test to all pregnant women.

Original languageEnglish (US)
Pages (from-to)169-174
Number of pages6
JournalAmerican family physician
Volume35
Issue number4
StatePublished - Jan 1 1987

ASJC Scopus subject areas

  • Family Practice

Fingerprint Dive into the research topics of 'Prenatal testing for maternal serum alpha-fetoprotein'. Together they form a unique fingerprint.

  • Cite this